Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study

被引：0
|
作者：
Buisson, A. [1 ]
Treton, X. [2 ]
Nachury, M. [3 ]
Uzzan, M. [4 ]
Bouguen, G. [5 ]
Hamadidi, A. Banana [1 ]
Amiot, A. [6 ]
Serrero, M. [7 ]
Fumery, M. [8 ]
Caillo, L. [9 ]
Hupe, M. [10 ]
Pereira, B. [1 ]
Altwegg, R. [11 ]
机构：
[1] CHU Clermont Ferrand, IBD Unit, Clermont Ferrand, France
[2] Paris IBD Ctr, IBD Unit, Paris, France
[3] IBD Unit, CHRU Lille, Lille, France
[4] CHU Creteil, IBD Unit, Creteil, France
[5] CHU Rennes, IBD Unit, Rennes, France
[6] AP HP Kremlin Bicetre, IBD Unit, Paris, France
[7] AP HM, IB Unit, Marseille, France
[8] CHU Amiens, IBD Unit, Amiens, France
[9] CHU Nimes, IBD Unit, Nimes, France
[10] CHU Grenoble, IBD Unit, Grenoble, France
[11] CHU Montpellier, IBD Unit, Montpellier, France
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0785
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0611
引用
收藏
页码：i1212 / i1212
页数：1
相关论文
共 50 条
  • [21] Ulcerative colitis: Tofacitinib under real-world conditions
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (12): : 1565 - +
  • [22] Editorial: real-world safety of tofacitinib in ulcerative colitis
    Taxonera, Carlos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 368 - 369
  • [23] Filgotinib in ulcerative colitis: early real-world experience in Southampton
    Taylor, Deborah
    Young, David
    Rahmany, Sohail
    Bettey, Marion
    Oppong, Philip
    Harris, Richard
    Smith, Trevor
    Felwick, Richard
    Gwiggner, Markus
    Cummings, Fraser
    GUT, 2023, 72 (SUPPL_2) : A113 - A113
  • [24] UPADACITINIB IS EFFECTIVE AND SAFE IN TOFACITINIB-EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-WORLD EXPERIENCE
    Cleveland, Noa
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Rubin, David T.
    GASTROENTEROLOGY, 2023, 164 (06) : S1129 - S1129
  • [25] Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience
    Cleveland, N. Krugliak
    Friedberg, S.
    Choi, D.
    Hunold, T.
    Choi, N. K.
    Garcia, N. M.
    Picker, E. A.
    Cohen, N. A.
    Cohen, R. D.
    Dalal, S. R.
    Pekow, J.
    Sakuraba, A.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 854 - 856
  • [26] Safety of tofacitinib and upadacitinib compared to other advanced therapies in ulcerative colitis: a large real-world comparison
    Fiorino, G.
    Allocca, M.
    D'Amico, F.
    Rusconi, F.
    Hernandez, G.
    Zilli, A.
    Parigi, T.
    Furfaro, F.
    Cosintino, R.
    Faggiani, R.
    Jairath, V
    Peyrin-Biroulet, L.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1996 - i1996
  • [27] ONE-YEAR COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERSUS TOFACITINIB FOR ULCERATIVE COLITIS: A MULTICENTER COHORT STUDY
    Dalal, Rahul S.
    Kallumkal, Govind
    Cabral, Heidy
    Barnes, Edward L.
    Allegretti, Jessica R.
    GASTROENTEROLOGY, 2024, 166 (05) : S56 - S57
  • [28] One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study
    Dalal, Rahul S.
    Kallumkal, Govind
    Cabral, Heidy J.
    Barnes, Edward L.
    Allegretti, Jessica R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (08): : 1628 - 1631
  • [29] SAFETY AND EFFECTIVENESS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS: A BRAZILIAN MULTICENTER REAL-WORLD STUDY
    Parra, Rogerio S.
    Azevedo, Matheus
    Chebli, Liliana A.
    Zabot, Gilmara P.
    Cassol, Ornella S.
    Lubini, Marcio
    Alves, Antonio, Jr.
    Teixeira, Fabio V.
    Kotze, Paulo G.
    Moraes, Antonio Carlos
    Santana, Genoile O.
    Froes, Renata
    Gasparetti, Newton, Jr.
    Feres, Omar
    Chebli, Julio
    GASTROENTEROLOGY, 2023, 164 (06) : S1004 - S1004
  • [30] Assessment of the real-world effectiveness of upadacitinib in patients with moderate-severe ulcerative colitis in a global real-world setting
    Seidelin, J. B.
    Marin-Jimenez, I
    Dawod, F.
    Lukanova, R.
    Jones, W.
    Morriset, P.
    Sharma, D.
    Siegel, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1261 - i1263
12345